Publications by authors named "Mmadili N Ilozumba"

Background: Cachexia accounts for about 20% of all cancer-related deaths and it is indicative of poor prognosis and progressive functional impairment. The role of the gut microbiome in the development of cachexia in colorectal cancer (CRC) patients has not been established.

Methods: Pre-surgical stool samples from n = 103 stage I-III CRC patients in the ColoCare Study were analyzed using 16S rRNA gene sequencing (Illumina) to characterize fecal bacteria.

View Article and Find Full Text PDF

Metastasis causes most cancer-related deaths in colorectal carcinoma (CRC), and microbiome markers may have prognostic value. We hypothesized that primary tumor microbiomes predict distant metastases. We analyzed 5-year metastasis-free survival (MFS) in a retrospective cohort of 900 ORIEN CRC tumor microbiomes (RNAseq).

View Article and Find Full Text PDF

Colorectal cancer (CRC) is the second overall leading cause of cancer death in the United States, with recurrence being a frequent cause of mortality. Approaches to improve disease-free survival (DFS) are urgently needed. The gut microbiome, reflected in fecal samples, is likely mechanistically linked to CRC progression and may serve as a non-invasive biomarker.

View Article and Find Full Text PDF
Article Synopsis
  • Cachexia, a condition linked to cancer and associated with a poor prognosis, accounts for about 20% of cancer-related deaths, yet the connection between Fusobacterium nucleatum (Fn) and cachexia in colorectal cancer (CRC) remains unclear.
  • In a study involving 87 CRC patients, researchers found that high levels of Fn in pre-surgical stool samples significantly increased the risk of developing cachexia six months after surgery.
  • These results are the first to connect Fn abundance with cachexia in CRC, highlighting potential biological mechanisms and treatment avenues; however, the study's small sample size calls for more research to confirm these findings.
View Article and Find Full Text PDF

Background: Excessive energy intake has been shown to affect the mammalian target of the rapamycin (mTOR) signaling pathway and breast cancer risk. It is not well understood whether there are gene-environment interactions between mTOR pathway genes and energy intake in relation to breast cancer risk.

Methods: The study included 1642 Black women (809 incident breast cancer cases and 833 controls) from the Women's Circle of Health Study (WCHS).

View Article and Find Full Text PDF

Background: Physical activity has been shown to affect the mammalian target of rapamycin (mTOR) signaling pathway and consequently breast carcinogenesis. Given that Black women in the USA are less physically active, it is not well understood whether there are gene-environment interactions between mTOR pathway genes and physical activity in relation to breast cancer risk in Black women.

Methods: The study included 1398 Black women (567 incident breast cancer cases and 831 controls) from the Women's Circle of Health Study (WCHS).

View Article and Find Full Text PDF

Background: Obesity is known to stimulate the mammalian target of rapamycin (mTOR) signaling pathway and both obesity and the mTOR signaling pathway are implicated in breast carcinogenesis. We investigated potential gene-environment interactions between mTOR pathway genes and obesity in relation to breast cancer risk among Black women.

Methods: The study included 1,655 Black women (821 incident breast cancer cases and 834 controls) from the Women's Circle of Health Study (WCHS).

View Article and Find Full Text PDF

Background: Aberrant activation of the mammalian Target of Rapamycin (mTOR) pathway has been linked to obesity and endocrine therapy resistance, factors that may contribute to Black-White disparities in breast cancer outcomes. We evaluated associations of race and clinicopathological characteristics with mRNA expression of key mTOR pathway genes in breast tumors.

Methods: Surgical tumor tissue blocks were collected from 367 newly diagnosed breast cancer patients (190 Black and 177 White).

View Article and Find Full Text PDF

Background: Triclosan, bisphenol A (BPA), and brominated flame retardants are environmental estrogenic endocrine-disrupting compounds that may influence the prognosis of breast cancer. We examined the urinary concentrations of these compounds and their associations with demographic characteristics and body fatness in a population of women with newly diagnosed breast cancer. Methods: Overnight urine collection and anthropometric measures were obtained from 302 participants.

View Article and Find Full Text PDF

Background: Genetic variation in one-carbon metabolism may affect nutrient concentrations and biological functions. However, data on genetic variants associated with blood biomarkers of one-carbon metabolism in US postmenopausal women are limited, and whether these associations were affected by the nationwide folic acid (FA) fortification program is unclear.

Objectives: We investigated associations between genetic variants and biomarkers of one-carbon metabolism using data from the Women's Health Initiative Observational Study.

View Article and Find Full Text PDF
Article Synopsis
  • Choline is important for one-carbon metabolism in the body, and this study investigates whether genetic variations affect levels of plasma choline and its metabolites among postmenopausal women.
  • The analysis involved 1,423 women, measuring plasma concentrations of several compounds linked to choline metabolism and examining genetic polymorphisms in specific genes related to this process.
  • Key findings include the identification of certain SNPs, particularly in the BHMT and BHMT2 genes, that significantly influence plasma levels of betaine and dimethylglycine, with vitamin B-12 status affecting these associations.
View Article and Find Full Text PDF